Forest Announces FDA Approval Of Teflaro(TM) For The Treatment Of Community-Acquired Bacterial Pneumonia And ABSSSI
Links shared publicly online about this topic.
- 757total visits
Forest Announces FDA Approval Of Teflaro(TM) For The Treatment Of Community-Acquired Bacterial Pneumonia And ABSSSI
View full resource at medicalnewstoday.com
Tags: Pneumonia, Bacterial Pneumonia, FDA, Forest Laboratories
Most Recently Shared on November 2, 2010 at 3:06 pm By:
Forest Announces FDA Approval Of Teflaro(TM) For The Treatment Of Community-Acquired Bacterial Pneumonia And ABSSSI http://mnt.to/3LWT
Also Shared By:
FDA approves Teflaro for treatment of community-acquired bacterial pneumonia
news-medical.net — “Forest Laboratories, Inc. announced today that Teflaro(ceftaroline fosamil), a broad-spectrum bactericidal cephalosporin with activity against both gram-positive and gram-negative microorganisms, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of community-acquired bacterial pneumonia (CABP), including cases caused by Streptococcus pneumoniae bacteremia, and acute bacterial skin and skin structure infection (ABSSSI), including cases caused by methicillin-resistant S” View full resource at news-medical.net
Most Recently Shared on October 30, 2010 at 4:33 pm By:
FDA approves Teflaro for treatment of community-acquired bacterial pneumonia: Forest Laboratories, Inc. announced ... http://bit.ly/ci6Cqx
Advertisement
MNT Dermatology News
@mnt_dermatology
Forest Announces FDA Approval Of Teflaro(TM) For The Treatment Of Community-Acquired Bacterial Pneumonia And ABSSSI http://mnt.to/3LWT
1 year ago...